CD34 and acute myeloid leukemia: Although, according to “The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia” the t(8;21)(q22;q22.1), RUNX1-RUNX1T1 represents a specific subgroup of “AML with recurrent genetic abnormalities”, several authors have shown that the expression of RUNX1-RUNXT1 transcript in human hematopoietic stem progenitor cells (HSPC) causes deregulated differentiation and increased self-renewal of CD34+ cells without inducing AML [19,26].